Published • loading... • Updated
Private Clinic Pauses Plasma Collection Months After Two Donors Die
The pause follows a Health Canada non-compliance notice and months of scrutiny after two donor deaths, as Grifols says it will work with regulators.
- On Friday, August 14, 2026, Grifols halted plasma collection at all 16 Canadian locations following a formal notice of non-compliance from Health Canada issued earlier this week.
- Scrutiny regarding two deaths in Winnipeg in October 2025 and January 2026 prompted the pause, as inspectors identified recurring, systemic deficiencies across several sites.
- Federal agency data indicates at least 25 serious adverse reactions have been reported at Grifols-operated clinics since 2018, with inspectors citing insufficient staff training and equipment maintenance.
- Citing "unfounded attention," Grifols proactively paused collection activities, while Minister of Health Marjorie Michel confirmed the closure will not impact the country's blood supply safety.
- The company plans to resume operations "as soon as practicable," though OPSEU/SEFPO Blood Services and Diagnostics Sector Chair Brent MacPherson is calling for immediate termination of the collection contract.
Insights by Ground AI
Podcasts & Opinions
16 Articles
16 Articles
Grifols, a Spanish company that administers 17 private blood plasma collection clinics in Canada, temporarily suspended donations in all units of the country on Friday. The decision takes place months after the death of two donors in Winnipeg, Manitoba, and one day after Health Canada, a federal regulatory body, issues a notification of non-compliance against one of the company's clinics.
·Rio de Janeiro, Brazil
Read Full Article
WellandTribune.ca+3 Reposted by 3 other sources
OPSEU/SEFPO: Permanently end for-profit plasma collection to protect public health
Toronto, Aug. 14, 2026 (GLOBE NEWSWIRE) -- The union that represents Canadian Blood Services (CBS) workers in Ontario is calling for an immediate termination of the blood-plasma collection contract with for-profit Spanish pharmaceutical company Grifols.
Coverage Details
Total News Sources16
Leaning Left6Leaning Right3Center5Last UpdatedBias Distribution43% Left
Bias Distribution
- 43% of the sources lean Left
43% Left
L 43%
C 36%
R 21%
Factuality
To view factuality data please Upgrade to Premium
